Cure through innovation
Breaking news
- 21 May 2026 Genethon and Ampersand Biomedicines announce partnership to design novel AAV vectors with enhanced tissue specificity for more effective and better tolerated gene therapies
- 19 May 2026 ASGCT 2026: Genethon presents results from three gene therapy programs in clinical development
- 19 May 2026 ASGCT 2026: Atamyo Therapeutics presents encouraging ATA-200 results in LGMD-R5
- 30 March 2026 Téléthon 2025: 100,548,314 euros raised
- 19 February 2026 Klaudia Kuranda joins Genethon and the Institute of Myology to create a center of expertise dedicated to immunology
- 10 October 2025 Progress in Treating Patients Immunised Against AAV Vectors Used in Gene Therapy